Could a light zap in the nose stop deadly ICU infections?
NCT ID NCT06867458
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new method to prevent serious lung and bloodstream infections in intensive care unit (ICU) patients. The treatment uses a special light and a blue dye to kill germs in the nose. Researchers enrolled 227 adults in the ICU and checked if the procedure was practical and reduced infection rates. The goal was to gather information for a larger, more definitive study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOSPITAL ACQUIRED INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Columbian Hospital
New Westminster, British Columbia, V3L 3W7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Artificial intelligence may forecast pneumonia after heart surgery
- Blood test showdown: which marker best spots ventilator pneumonia?
- New study aims to uncover why some pneumonia patients need ventilators
- Pneumonia's hidden heart risk: new study tracks Long-Term damage
- One-Hour test could revolutionize pneumonia treatment in hospitals
- Hospital study reveals key risk factors for superbug pneumonia